Loading clinical trials...
Loading clinical trials...
It is known that morbidly obese patients are often accompanied by cardiovascular complications such as hypertension, cardiac hypertrophy, and diastolic dysfunction, and are known to increase the risk ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seoul National University Bundang Hospital
NCT05569681 · Morbid Obesity
NCT07289555 · Morbid Obesity, Bariatric Surgery, and more
NCT07050212 · Remimazolam, Dexmedetomidine, and more
NCT07046364 · Pediatric, Neurosurgery, and more
NCT05783466 · Morbid Obesity
Seoul national university Bundang hospital
Seongnam-si
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions